FDA Launches Major Review of CGMPs

Pharmaceutical Technology, Pharmaceutical Technology-10-02-2002, Volume 26, Issue 10

FDA is set to revise CGMPs to encourage new manufacturing technologies and develop improved agency policies to ensure drug quality and safety.

Related Content:

Regulatory/GMP ComplianceRegulatory WatchPharmaceutical Technology-10-02-2002
Biologic Standards in the Pharmacopoeias: An Update
Advancing Global Collaboration for Drug Testing, Regulation, and Manufacturing
Regulatory Compliance Versus Real Compliance